BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20175835)

  • 1. Systemic sclerosis up to date.
    Takehara K
    J Dermatol; 2010 Jan; 37(1):2. PubMed ID: 20175835
    [No Abstract]   [Full Text] [Related]  

  • 2. B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis.
    Hasegawa M
    J Dermatol; 2010 Jan; 37(1):3-10. PubMed ID: 20175836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets.
    Gabrielli A; Svegliati S; Moroncini G; Luchetti M; Tonnini C; Avvedimento EV
    Autoimmun Rev; 2007 Dec; 7(2):121-6. PubMed ID: 18035321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New developments in the pathogenesis of systemic sclerosis.
    Sakkas LI
    Autoimmunity; 2005 Mar; 38(2):113-6. PubMed ID: 16040330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis.
    Hasegawa M; Matsushita Y; Horikawa M; Higashi K; Tomigahara Y; Kaneko H; Shirasaki F; Fujimoto M; Takehara K; Sato S
    Arthritis Rheum; 2009 Nov; 60(11):3465-75. PubMed ID: 19877032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Electron microscopy study of pathological collagen fibril formation in systemic scleroderma].
    Ptashekas RS; Vaĭtkene DI
    Arkh Patol; 1984; 46(7):49-54. PubMed ID: 6477175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of tumor necrosis factor receptor p55 impairs collagen turnover in experimentally induced sclerodermic skin fibroblasts.
    Murota H; Hamasaki Y; Nakashima T; Yamamoto K; Katayama I; Matsuyama T
    Arthritis Rheum; 2003 Apr; 48(4):1117-25. PubMed ID: 12687556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate has no antifibrotic effect in bleomycin-induced experimental scleroderma.
    Ozgen M; Koca SS; Isik A; Ozercan IH
    J Rheumatol; 2010 Mar; 37(3):678-9. PubMed ID: 20197571
    [No Abstract]   [Full Text] [Related]  

  • 9. New prospects for autoimmune disease therapy: B cells on deathwatch.
    St Clair EW; Tedder TF
    Arthritis Rheum; 2006 Jan; 54(1):1-9. PubMed ID: 16385491
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis.
    Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Dermatol Sci; 2005 Jul; 39(1):1-7. PubMed ID: 15885984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Success of prednisone in the treatment of a patient with sarcoidosis and systemic sclerosis: Report of a case.
    Borges da Costa J; Mayer-da-Silva A; Soares de Almeida LM; Marques Gomes M
    Dermatol Online J; 2009 Mar; 15(3):11. PubMed ID: 19379655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings of the third international workshop on scleroderma research.
    Black CM; Korn JH
    Matrix Biol; 1995 Dec; 14(9):699-704. PubMed ID: 8785584
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms of skin fibrosis in systemic sclerosis.
    Jinnin M
    J Dermatol; 2010 Jan; 37(1):11-25. PubMed ID: 20175837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of skin fibrosis and autoantibodies by infusion of immunocompetent cells from tight skin mice into C57BL/6 Pa/Pa mice.
    Phelps RG; Daian C; Shibata S; Fleischmajer R; Bona CA
    J Autoimmun; 1993 Dec; 6(6):701-18. PubMed ID: 8155252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Disorders of cellular immunity in systemic scleroderma].
    Sierakowski SJ; Kucharz EJ
    Przegl Lek; 1988; 45(7):592-7. PubMed ID: 3070641
    [No Abstract]   [Full Text] [Related]  

  • 16. T cells, B cells, and polarized immune response in the pathogenesis of fibrosis and systemic sclerosis.
    Chizzolini C
    Curr Opin Rheumatol; 2008 Nov; 20(6):707-12. PubMed ID: 18946333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins and the vasculopathy of systemic sclerosis: potential therapeutic agents?
    Derk CT; Jimenez SA
    Autoimmun Rev; 2006 Jan; 5(1):25-32. PubMed ID: 16338208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice.
    Yamamoto T; Takahashi Y; Takagawa S; Katayama I; Nishioka K
    J Rheumatol; 1999 Dec; 26(12):2628-34. PubMed ID: 10606374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [D-penicillamine and collagen].
    Camus JP; Koeger AC
    Ann Biol Clin (Paris); 1986; 44(3):296-9. PubMed ID: 3538948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The microvascular endothelium in scleroderma.
    Kahaleh B
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v14-5. PubMed ID: 18784128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.